The extent of dorsolateral prefrontal cortex (DLPFC) plasticity in Alzheimer disease (AD) and its association with working memory are not known.
P athologic change and dysfunction in the frontal lobes are common in Alzheimer disease (AD) and are present from an early stage of the illness. [1] [2] [3] In particular, patients with early AD experience dorsolateral prefrontal cortex (DLPFC) dysfunction. 4 Dysfunction of the DLPFC is manifested by impairment of working memory and specifically its executive component in early AD. 5, 6 Furthermore, the DLPFC provides neural substrate for cognitive reserve in individuals at risk for developing AD. [7] [8] [9] The DLPFC is able to compensate for neuropathologic changes and dysfunction in other regions owing to its ability to experience neuroplasticity. [10] [11] [12] [13] Thus, understanding the mechanisms that underlie DLPFC dysfunction is important to design effective interventions in patients with AD. Neuroplasticity refers to the ability of the brain to modify its function or structure in response to experience, use, or pathologic change. [14] [15] [16] [17] [18] Long-term potentiation (LTP) is a prototype of functional neuroplasticity and refers to use-and timedependent strengthening of synapses. 15, [19] [20] [21] Paired associative stimulation (PAS) is a transcranial magnetic stimulation (TMS) paradigm that is considered to be a standard in the field to assess LTP-like activity in the human cortex. [22] [23] [24] [25] Paired associative stimulation induces LTP-like activity (hereafter referred to as PAS-LTP) through the pairing of peripheral nerve electrical stimulation (eg, median nerve at the wrist) with TMS of the contralateral cerebral cortex. 26, 27 Through this pairing, these 2 stimulations occur contemporaneously in the cortex and activate presynaptic and postsynaptic neurons to induce PAS-LTP. 26, 27 Paired associative stimulation was originally applied to the human motor cortex, and PAS-LTP was assessed through changes in motor-evoked potentials. 26 Subsequently, PAS-LTP was shown to be induced in the human DLPFC by combining median nerve stimulation at the wrist with TMS to the contralateral DLPFC and recording changes in the cortical-evoked activity over the DLPFC using scalp electroencephalography (EEG). 28, 29 The rationale for using median nerve stimulation in combination with DLPFC is based on extensive evidence of connectivity between frontal and somatosensory cortices in rodents [30] [31] [32] and primates 33 and the ability of median nerve stimulation to induce N24 somatosensory-evoked potential in the human DLPFC.
34,35
The DLPFC is critical for working memory, [36] [37] [38] [39] and DLPFC activation correlates with working memory load. 40 Working memory is supported by reentrant circuits between the DLPFC and posterior cortices. 38 Robust neuroplasticity within the DLPFC is essential to maintain these networks. 41, 42 Thus, studying DLPFC plasticity is essential for understanding the mechanisms underlying working memory deficits in AD. A few studies have shown impaired motor cortex plasticity in mild to moderate AD. [43] [44] [45] [46] Some studies showed impaired motor cortex plasticity using PAS, 43 ,44 whereas others used theta burst stimulation. 45, 46 However, plasticity changes in the DLPFC of patients with AD have not been reported. Thus, we conducted the first study, to our knowledge, to investigate DLPFC plasticity in AD and its association with working memory. The primary aim of this study was to compare PAS-LTP in the DLPFC between participants with AD and age-matched healthy control participants. We hypothesized that PAS-LTP (ie, plasticity) in the DLPFC would be impaired in participants with AD.
The secondary aim was to compare working memory between controls and participants with AD and to determine whether PAS-LTP in the DLPFC is associated with working memory performance. We hypothesized that working memory would be significantly associated with PAS-LTP.
Methods
The study was conducted at the Centre for Addiction and Mental Health, Toronto, Ontario, Canada. The study was approved by the research ethics board of the center, and all participants provided written informed consent.
Participants
Participants with AD were recruited based on referrals from memory clinics in Toronto or in response to advertisements. They were included if they met (1) the core criteria for probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer Disease and Related Disorders Association (NINCDS-ADRDA) 47 and (2) the diagnostic criteria for dementia due to probable AD according to the DSM-IV-TR. 48 Other key inclusion criteria were a score of 17 or above on the Mini-Mental State Examination (MMSE; range, 0-30, with higher scores indicating better performance) 49 ; age of 65 years or older; and treatment with a stable dose of a cognitive enhancer (ie, donepezil hydrochloride, galantamine hydrobromide, memantine hydrochloride, or rivastigmine tartrate) for at least 3 months. Age-matched, right-handed controls were recruited using advertisements and from a database (further eligibility criteria are given in eMethods in the Supplement). On the basis of a previous study of PAS at our center, 28 a sample of 32 participants with AD and 16 controls was determined to be needed to provide 80% power at α = .05 to detect a significant difference in DLPFC plasticity between the 2 groups. 56 In this study, n was 1 or 2 because participants with AD could not generate meaningful data with the 3-back condition. The n-back task was performed immediately before PAS and on the same day. To assess performance accuracy, we used the A′ statistic, which takes into account true-positive and false-positive findings 57, 58 (eMethods in the Supplement).
DLPFC Localization
Brodmann area 9/46 in the DLPFC was localized through neuronavigation techniques as previously described. 59 The DLPFC site of stimulation corresponded to the F3 or F5 EEG electrode (eMethods in the Supplement).
EEG Recording and Data Analysis
The EEG was recorded during the PAS protocol (TMS-EEG) using 64 channels per 10-20 system 60 as previously described. 59 The EEG data were cleaned using the EEGLAB toolbox (Matlab) and referenced to the mean for further analyses (eMethods in the Supplement).
PAS Administration and Assessment of DLPFC Plasticity
Paired associative stimulation was administered using a published protocol. 28 The protocol involved electrical stimulation of the right median nerve at the wrist followed by TMS of the left DLPFC after a 25-millisecond delay. During the procedure, participants were intermittently asked to report their current count of sensory stimuli, which was recorded against the actual count. The absolute difference between the participant's count and the actual count (count difference) was used as an index of attention during the PAS procedure because attention is known to be critical for PAS-LTP. 26, 28 Pre-PAS corticalevoked activity at the DLPFC was indexed using a train of 100 monophasic TMS pulses at 0.1 Hz administered to the left DLPFC using a 7-cm figure-8 coil and a commercially available module (BiStim; Magstim Company Ltd). We used a rectified area under the curve for TMS-evoked potential to calculate cortical-evoked activity, in line with previous publications on TMS-EEG 59,61 and DLPFC plasticity. 28,29 At 0, 17, and 34 minutes after PAS, cortical-evoked activity was indexed using the same procedures. These times were chosen on the basis of previous research showing the maximum likelihood of potentiation during this interval for motor cortex 62, 63 and the DLPFC. 28, 29 We defined PAS-LTP (ie, DLPFC plasticity) as the maximum potentiation of cortical-evoked activity at 1 of these 3 times and measured using the ratio of post-PAS to pre-PAS cortical-evoked activity as in several previous publications on PAS. 28, 29, 64, 65 Finally, to show the changes in TMSevoked response potential before and after PAS in both groups, we plotted the TMS-evoked response potential before and after PAS at the time of maximum potentiation of corticalevoked activity for each group of participants (eMethods in the Supplement).
Statistical Analysis
First, we compared the demographic and baseline cognitive and neurophysiological variables between participants with AD and controls by using an independent-samples paired t test or χ 2 test. Second, to test our primary hypothesis, we performed an analyses of covariance (ANCOVA) with PAS-LTP as the dependent variable, group (AD vs control) as the independent fixed factor, the count difference as a covariate accounting for the potential confounding effect of attention during PAS, and pre-PAS cortical-evoked activity as another covariate accounting for baseline excitability (which can affect response to PAS). Then, we performed 2 additional ANCOVAs, one using the 1-back A′ and the second using the 2-back A′ as dependent variables, group (AD vs control) as the independent fixed factor, and educational attainment as a covariate potentially confounding differences in working memory performance between participants with AD and controls. Finally, we performed 2 multivariable regression models, the first using the 1-back A′ and the second using the 2-back A′ as dependent variables, with age, educational attainment, count difference, and PAS-LTP entered simultaneously as the independent variables. The Cohen d statistic was used to estimate effect sizes when appropriate. All analyses were performed using SPSS Statistical software for Windows (version 24.0; IBM). We found a significant association of group with PAS-LTP (F 1,44 = 5.90; P = .02); when controlling for pre-PAS cortical-evoked activity (F 1,44 = 0.28; P = .60) and count difference (F 1,44 = 0.02; P = .88), both of which had no influence on PAS-LTP, participants with AD experienced significantly less PAS-LTP than did controls (Cohen d =0 . 77 ;P = .01). This finding was also revealed when plotting the TMS-evoked response potential before and after PAS for participants with AD and controls ( Figure 1 and Figure 2 ).
Results

Demographic and Baseline Characteristics
Working Memory
As expected, we found a significant association of presence of AD with working memory using the 1-back A′ (F 1,45 = 32.6; P < .001) and the 2-back A′ (F 1,41 = 69.9; P < .001); controlling for educational attainment had no influence on the 1-back 
Discussion
This study is the first, to our knowledge, to provide evidence of DLPFC plasticity deficits in patients with AD using TMS-EEG to assess PAS-LTP. To our knowledge, this study also demonstrates for the first time, to our knowledge, an association between DLPFC plasticity and working memory. These findings extend current knowledge on neuroplasticity deficits in AD. 43, 45, 66 Assessing plasticity directly from the DLPFC using TMS-EEG has several advantages. First and notwithstanding the possibility that deficits in DLPFC plasticity may be an upstream effect of subcortical pathologic changes in regions such as the locus ceruleus and dorsal raphe nuclei, 67 TMS-EEG allows the development of a direct marker of DLPFC plasticity rather than more peripheral markers (eg, motor-evoked potential or serum markers of neuroplasticity). Second, the feasibility of this procedure in patients with AD makes it possible to study mechanisms underlying cognitive dysfunction in AD. Robust synaptic plasticity is critical for cognitive processes such as learning and memory, 68-70 and impaired plasticity could be the final common neurophysiologic mechanism for cognitive deficits of AD. Third, DLPFC plasticity could be a potential target to enhance cognition with interventions such as transcranial direct-current or magnetic stimulation.
71-73
Noninvasive DLPFC stimulation may also positively affect plasticitylike phenomena in the motor cortex and have positive effects beyond cognition separate from plasticity.
74
The mechanisms by which AD pathologic changes could specifically impair neuroplasticity remain unclear. A reciprocal association between DLPFC plasticity and brain pathologic features in AD may exist.
75-78 Furthermore, synaptic 
Participants with AD Controls
The correlations between the paired associative stimulation induction of long-term potentiation (PAS-LTP) at the left DLPFC site of stimulation and working memory performance on n-back task in a combined sample of participants with Alzheimer disease (AD) and control individuals. PAS-LTP was calculated as potentiation of cortical-evoked activity, and working memory performance was calculated as the A' statistic, which is a composite measure of true-positive and false-positive rates. For the 1-back task, 48 participants were included (Pearson r = 0.35; P = .01); for the 2-back task, 44 participants were included (Pearson r = 0.43, P = .003).
dysfunction could lead to a vicious cycle of aberrant neuroplasticity and amyloid deposition, resulting in progression of AD. 18 In contrast, several studies have shown a positive role of low levels of endogenous amyloid in maintaining neuroplasticity 79, 80 ; thus, the interaction between amyloid and neuroplasticity is complex. Impaired neuroplasticity could also be associated with network dysfunction in AD.
81,82
Impairment of default mode network activity is well known in AD and is associated with increased amyloid deposition and cognitive decline. 83, 84 Thus, future studies should assess the association of neuroplasticity with network dysfunction in AD using techniques such as corticocortical PAS. [85] [86] [87] The effect of synaptic and neuronal loss on neuroplasticity should be investigated by combining studies of neuroplasticity with markers of neural integrity in vivo or by studying the association between neuroplasticity and postmortem brain pathologic changes in AD. Long-term potentiation depends on intact glutamate signaling at the synapses.
69,88 However, the association between glutamate receptor dysfunction and neuroplasticity in AD is not well understood. Similarly, the association of other neurotransmitters, such as dopamine, with neuroplasticity in AD is not well understood. 89 Deficits in acetylcholine signaling are considered to be a hallmark of AD, but the association of acetylcholine with neuroplasticity in AD is not fully known. [90] [91] [92] Thus, future studies should use magnetic resonance spectroscopy or positron emission tomographic imaging to study neurotransmitter systems in conjunction with PAS. We also found an association between DLPFC plasticity and working memory in participants with AD and controls. This association seems to be partially driven by differences in distributions of working memory performance and DLPFC plasticity in participants with AD and controls. Although this finding supports the association between DLPFC plasticity and working memory, future research should include participants with mild cognitive impairment whose performance and DLPFC plasticity would be expected to range between that of AD and control groups. In addition, future studies could assess the association between DLPFC plasticity and other cognitive or functional measures in AD. Finally, noninvasive brain stimulation has been shown to enhance motor cortex plasticity 93 shown variability in results for DLPFC noninvasive brain stimulation to enhance working memory. Thus, future studies should consider assessment of DLPFC plasticity and working memory before and after the intervention. Some differences between the existing literature and the results of our study should be noted. Several studies 99-101 have found decreased resting motor threshold and increased cortical excitability in AD. We found no differences in resting motor threshold between the AD and control groups in our study. This finding could be attributable to the relatively milder illness in the participants with AD in our study. 99,100,102 One study 99 reported an association between motor threshold and severity of illness in AD. We did not find any difference in baseline DLPFC cortical-evoked activity between the AD and control groups in our study. Furthermore, cortical excitability was not associated with PAS-LTP in our study, which suggests that DLPFC plasticity deficits may occur before changes in cortical excitability.
Limitations
This study has several limitations. First, although the sample size was defined a priori, it was relatively small, which limited our ability to conduct subgroup analyses (eg, based on sex or medications). However, the sample size was sufficient to detect DLPFC plasticity deficits because of the moderate to large effect size that we observed. One study has shown that combined treatment with acetylcholinesterase inhibitors and memantine may restore motor cortex plasticity in AD, 66 whereas
another study 103 has shown that memantine may block motor cortex plasticity in healthy individuals. Only 2 participants with AD in our study were using memantine, and thus it is unlikely to have caused a meaningful effect on our results. Second, the diagnosis of AD in our study was based on clinical assessment and did not incorporate pathologic markers of AD (eg, amyloid or tau imaging). However, a clinical diagnosis of AD based on the NINCDS-ADRDA criteria has been shown to be highly reliable. 104,105 Third, we did not correct for coil-to-cortex distance in determining TMS intensity of stimulation. However, we individualized the intensity of stimulation by assessing resting motor threshold and TMS intensity required to produce a 1-mV motor-evoked potential; this procedure is expected to adjust for cortical atrophy. Furthermore, our measure of plasticity (ie, PAS-LTP) is a ratio of post-PAS to pre-PAS cortical-evoked activity, which controls for baseline cortical-evoked activity. Fourth, to remove the TMS artifact, we excluded early TMS-evoked activity (first 50 milliseconds), which could have excluded early glutamatemediated activity.
106,107
Conclusions
We found that older patients with AD have impaired DLPFC plasticity compared with healthy older individuals, and impaired DLPFC plasticity is associated with impairment in working memory. Improving our understanding of the association between DLPFC plasticity and working memory may advance our understanding of neurophysiologic mechanisms underlying working memory deficits in AD. Ultimately, this process may lead to novel treatment interventions to treat or prevent the cognitive deficits of AD. Future studies are now needed to further define the association of DLPFC plasticity with other biomarkers from functional brain imaging, amyloid and tau brain imaging, peripheral and central neurotransmitter studies, and postmortem pathologic studies. Finally, longitudinal studies of DLPFC plasticity in response to treatment interventions are required to demonstrate its relevance as a treatment target in AD and related disorders. and only the participants who passed this assessment were included. Age matched, right handed healthy control (HC) participants were recruited via advertisements and from a database. HC participants were included in the study if they met the following inclusion criteria: age 65 or above, willingness and ability to speak English, willingness and ability to provide informed is a working memory task that requires participants to decide whether a letter presented on a monitor is the same as, or different from a letter presented n trials back. When the letter is the same, the trial is a Target trial. When the letter is different, the trial is a Non-Target trial. In our study, n was either 1 or 2 because AD participants could not generate meaningful data with 3-back condition. The n-back task also includes a 0-back condition during which participants respond to every letter presented, assessing pure attention to the task. The n-back letters are black capital letters presented for 250 ms followed by a delay period of 3000 ms during which the participant is required to respond. Then, a plus sign is presented to indicate the end of each and -1 otherwise. Max (H, F) equals either H or F, whichever is greater 14 . has advantages over other signal detection measures such as as it is free of assumptions of normality for signal and noise.
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EEG Data Analysis: EEG data were down-sampled to 1000 Hz and segmented from -1000 ms to 2000 ms relative to the onset of TMS pulse, and baseline corrected with respect to the prestimulus interval -500 ms to -110 ms. To avoid TMS artifacts, EEG data were re-segmented from 25 ms to 2000 ms. Thereafter, EEG data were digitally filtered by using second order, Butterworth, zero-phase shift 1-55 Hz band pass filter (24dB/Oct). EEG recordings from all EEG sessions (pre-PAS, and 0, 15, and 30 min post-PAS) were concatenated together. Initially, EEG data were visually inspected to eliminate trials and channels that were highly contaminated with noise (muscle activity, electrode artifacts). Then, an electrodes-by-trials matrix of ones was created and assigned a value of zero if an epoch had: (1) amplitude larger than +/-150 V; or (2) amplitude larger than mean +/-three times standard deviation of all trials or (3) power spectrum that violated 1/f power law. An electrode was rejected if its corresponding row had more than 60% of columns (trials) coded as zeros. An epoch was removed if its corresponding column had more than 20% of rows (electrodes) coded as zeros. Then an independent component analysis (ICA) (EEGLAB toolbox; Infomax algorithm) was performed to remove eyeblink traces, muscle artifacts, and other noise from the EEG data. Finally, data was re-referenced to the average for further analysis.
PAS Administration and Assessment of DLPFC plasticity: PAS was administered using previously established protocol 5 . It involved electrical stimulation of the right median nerve at the wrist followed by TMS of the left DLPFC after a 25-ms delay. Electrical stimulation of the median nerve was delivered at 300% of the sensory threshold paired with TMS pulse delivered at the stimulus intensity required to produce peak-to-peak motor evoked potential equivalent to one millivolt and frequency of 0.1Hz for a 30-min period to deliver a total of 180 PAS pairs.
Participants were instructed to focus their attention at the sensory stimuli to their right wrist and count the number of stimuli delivered during the 30-min period. Participants were not aware of the frequency or total number of the stimuli to be delivered. During the procedure participants were intermittently asked to report their current count of sensory stimuli which was recorded against the actual count. The absolute difference between the participant's count and the actual count (Count Difference) was used as an index of attention during the PAS procedure given that attention is known to be critical for PAS-LTP 5, 19 . A Count Difference of 0 indicates "perfect" attention during PAS. Pre-PAS, cortical-evoked activity (CEA) of the DLPFC was indexed using a train of 100 monophasic TMS pulses at 0.1 Hz administered to the left DLPFC using a 7 cm figure-of-eight coil and a Bistim module (Magstim Company Ltd., UK). CEA from the EEG electrodes located over the left DLPFC was recorded using Neuroscan (Compumedics Ltd.). In order to measure the effect of PAS, first, CEA for each session was calculated by averaging the response over all epochs. Second, using Hilbert transform the area between 50-275 ms post TMS pulse was selected to calculate the overall CEA. The first interval (i.e., 50 ms) was chosen because it represents the earliest artefact-free data and the second interval (i.e., 275 ms) was chosen as it is thought to be important for gamma-aminobutyric acid receptor activity that is critical for paired pulse paradigms 20 . We used rectified area under the curve for TMS evoked potential to calculate cortical evoked activity in line with previous publications on TMS-EEG 15, 21 and DLPFC plasticity 5, 22 . At 0, 17, and 34 min post-PAS CEA was indexed following the same procedures used for pre-PAS as described above. These time points were chosen based on previous research showing the maximum likelihood of potentiation during this interval both for motor cortex 23, 24 and the DLPFC 5, 22 and the fact that the delivery of 100 pulses at 0.1 Hz takes approximately 16 minutes. DLPFC plasticity, i.e. PAS-LTP, was defined as potentiation of CEA and measured using the ratio of post-PAS to pre-PAS CEA. As the post-PAS timing of maximum potentiation of CEA could vary among participants, we selected the maximum CEA ratio for each participant post-PAS. This method has been used in several previous publications has been used in several previous publications 5, 22, 25, 26 and has been shown to adequately correct for variability in baseline CEA in response to TMS.
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